Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC

Clinical trial NCT02991651 · TERMINATED

Trial details

NCT number: NCT02991651
Sponsor: Io Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer, Nonsmall Cell

Start date: 2016-12-07
Primary completion: 2025-05-09
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.